These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16141405)

  • 1. Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits.
    Nicholls SJ; Cutri B; Worthley SG; Kee P; Rye KA; Bao S; Barter PJ
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2416-21. PubMed ID: 16141405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
    Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ
    Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin.
    de Haan W; de Vries-van der Weij J; van der Hoorn JW; Gautier T; van der Hoogt CC; Westerterp M; Romijn JA; Jukema JW; Havekes LM; Princen HM; Rensen PC
    Circulation; 2008 May; 117(19):2515-22. PubMed ID: 18458167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins.
    Asztalos BF; Le Maulf F; Dallal GE; Stein E; Jones PH; Horvath KV; McTaggart F; Schaefer EJ
    Am J Cardiol; 2007 Mar; 99(5):681-5. PubMed ID: 17317371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of atorvastatin on apolipoprotein E and AI kinetics in patients with type 2 diabetes.
    Bach-Ngohou K; Ouguerram K; Frénais R; Maugère P; Ripolles-Piquer B; Zaïr Y; Krempf M; Bard JM
    J Pharmacol Exp Ther; 2005 Oct; 315(1):363-9. PubMed ID: 16014756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term atorvastatin treatment does not modify neointimal morphology but reduces MMP-2 expression in normocholesterolemic rabbit stented arteries.
    Collin B; Busseuil D; Korandji C; Zeller M; Cottin Y; Duvillard L; Rioufol G; Pitois-Merli I; Rochette L
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):428-36. PubMed ID: 16633086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
    Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
    J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atorvastatin on SR-BI expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits.
    Zhao SP; Wu ZH; Hong SC; Ye HJ; Wu J
    Clin Chim Acta; 2006 Mar; 365(1-2):119-24. PubMed ID: 16185675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin.
    Kühnast S; van der Hoorn JW; van den Hoek AM; Havekes LM; Liau G; Jukema JW; Princen HM
    J Hypertens; 2012 Jan; 30(1):107-16. PubMed ID: 22134386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.
    Jukema JW; Liem AH; Dunselman PH; van der Sloot JA; Lok DJ; Zwinderman AH
    Curr Med Res Opin; 2005 Nov; 21(11):1865-74. PubMed ID: 16307708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
    Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
    Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
    Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity.
    Harangi M; Mirdamadi HZ; Seres I; Sztanek F; Molnár M; Kassai A; Derdák Z; Illyés L; Paragh G
    Transl Res; 2009 Apr; 153(4):190-8. PubMed ID: 19304278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib combined with atorvastatin prevents progression of atherosclerosis.
    Raval M; Frank PG; Laury-Kleintop L; Yan G; Lanza-Jacoby S
    J Surg Res; 2010 Oct; 163(2):e113-22. PubMed ID: 20538289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-arginine plus atorvastatin for prevention of atheroma formation in genetically hypercholesterolaemic rabbits.
    Rasmusen C; Moinard C; Martin C; Tricottet V; Cynober L; Couderc R
    Br J Nutr; 2007 Jun; 97(6):1083-9. PubMed ID: 17391569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI.
    Yonemura A; Momiyama Y; Fayad ZA; Ayaori M; Ohmori R; Kihara T; Tanaka N; Nakaya K; Ogura M; Taniguchi H; Kusuhara M; Nagata M; Nakamura H; Tamai S; Ohsuzu F
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):222-8. PubMed ID: 19242355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties.
    Uyuklu M; Meiselman HJ; Baskurt OK
    Clin Hemorheol Microcirc; 2007; 36(1):25-33. PubMed ID: 17211059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol.
    Bergheanu SC; Van Tol A; Dallinga-Thie GM; Liem A; Dunselman PH; Van der Bom JG; Jukema JW
    Curr Med Res Opin; 2007 Sep; 23(9):2235-40. PubMed ID: 17692153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of atorvastatin on high-density lipoprotein apolipoprotein A-I production and clearance in the New Zealand white rabbit.
    Rashid S; Uffelman KD; Barrett PH; Lewis GF
    Circulation; 2002 Dec; 106(23):2955-60. PubMed ID: 12460878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.